1,845.95
-38.80
(-2.06%)
At close: January 10 at 3:28:54 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
9,044,959.00
8,190,663.00
6,658,984.00
5,595,574.00
4,500,604.00
Cost of Revenue
5,454,036.00
4,983,866.00
3,971,760.00
3,262,850.00
2,399,939.00
Gross Profit
3,590,923.00
3,206,797.00
2,687,224.00
2,332,724.00
2,100,665.00
Operating Expense
2,647,751.00
2,422,106.00
2,390,534.00
2,657,180.00
2,596,901.00
Operating Income
943,172.00
784,691.00
296,690.00
-324,456.00
-496,236.00
Net Non Operating Interest Income Expense
21,439.00
-3,875.00
-322,842.00
-330,372.00
-514,738.00
Pretax Income
1,151,670.00
919,452.00
552,469.00
-568,987.00
-952,489.00
Tax Provision
--
-31,191.00
--
--
--
Net Income Common Stockholders
1,195,451.00
921,665.00
463,183.00
-19,512.00
-1,165,300.00
Diluted NI Available to Com Stockholders
1,195,451.00
921,665.00
463,183.00
-19,512.00
-1,165,300.00
Basic EPS
23.87
19.06
11.35
-0.48
-28.55
Diluted EPS
23.87
19.06
11.35
-0.48
-28.55
Basic Average Shares
50,719.01
48,365.18
40,816.40
40,816.40
40,816.40
Diluted Average Shares
50,719.01
48,365.18
40,816.40
40,816.40
40,816.40
Rent Expense Supplemental
--
33,417.00
10,160.00
15,809.00
15,061.00
Total Expenses
8,101,787.00
7,405,972.00
6,362,294.00
5,920,030.00
4,996,840.00
Net Income from Continuing & Discontinued Operation
1,155,424.00
921,665.00
463,183.00
-19,512.00
-1,165,300.00
Normalized Income
1,159,981.70
926,222.70
130,930.00
-609,342.00
-971,257.00
Interest Income
--
163,481.00
6,180.00
4,188.00
7,326.00
Interest Expense
138,231.00
163,545.00
322,257.00
320,117.00
513,356.00
Net Interest Income
21,439.00
-3,875.00
-322,842.00
-330,372.00
-514,738.00
EBIT
1,289,901.00
1,082,997.00
874,726.00
-248,870.00
-439,133.00
EBITDA
1,637,529.00
1,415,368.00
1,422,594.00
621,376.00
650,031.00
Reconciled Cost of Revenue
5,454,036.00
4,983,866.00
3,971,760.00
3,262,850.00
2,399,939.00
Reconciled Depreciation
347,578.00
332,371.00
547,868.00
870,246.00
1,089,164.00
Net Income from Continuing Operation Net Minority Interest
1,155,424.00
921,665.00
530,934.00
-604,214.00
-952,489.00
Total Unusual Items Excluding Goodwill
-6,511.00
-6,511.00
400,004.00
5,128.00
18,768.00
Total Unusual Items
-6,511.00
-6,511.00
400,004.00
5,128.00
18,768.00
Normalized EBITDA
1,644,040.00
1,421,879.00
1,022,590.00
616,248.00
631,263.00
Tax Rate for Calcs
0.00
0.00
--
--
--
Tax Effect of Unusual Items
-1,953.30
-1,953.30
--
--
--
3/31/2021 - 11/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LINCOLN.BO LINCOLN PHARMACEUTICALS LTD.
805.75
-0.43%
AARTIPHARM.BO Aarti Pharmalabs Limited
669.05
+1.53%
KERALAYUR.BO Kerala Ayurveda Limited
400.75
-0.88%
WOCKPHARMA.BO Wockhardt Limited
1,386.95
-3.76%
NEULANDLAB.BO Neuland Laboratories Limited
14,025.25
-4.07%
GLAND.BO Gland Pharma Limited
1,784.35
-2.35%
NATCOPHARM.BO NATCO Pharma Limited
1,235.50
-4.15%
DRREDDY.BO Dr. Reddy's Laboratories Limited
1,354.20
-1.27%
VTRS Viatris Inc.
11.67
-2.42%
TEVA Teva Pharmaceutical Industries Limited
20.94
-2.56%